The FDA has yet to out­line its plans, leaving plenty of spec­u­la­tion about whether the agency will reg­u­late dif­ferent cigars dif­fer­ently — without cre­ating loopholes.

If they can’t figure out a way to keep this thing from being gamed, then they basi­cally shouldn’t make any exemp­tions,” said Richard A. Day­nard, a North­eastern Uni­ver­sity law pro­fessor and pres­i­dent of its Public Health Advo­cacy Institute.

Read the article at The Washington Post →